Kim Eng Research in a Mar 1 research report says: “RMG delivered a remarkable 13th consecutive year of revenue growth since listing and 7th consecutive year of double-digit net profit growth.
Raffles Medical Group rated buy
written by Editor on March 2nd, 2010 |
No Comments

















